Skip to main content

Table 2 Results of whole-body bone SPECT/CT and FCH PET/CT for the different sites evaluated

From: Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

Relapse site

N (%)

Bone

Lymph node

Local

Total

Positive

Negative

Equivocal

Positive

Positive

Positive

Bone SPECT/CT

27 (23.5%)

81 (70.5%)

7 (6%)

/

/

27 (23.5%)

FCH PET/CT

28 (24%)

85 (74%)

2 (1.5%)

45 (41.5%)

35 (32%)

85 (74%)

BVC

30 (26%)

85 (74%)

0 (0%)